{
    "nctId": "NCT06533670",
    "briefTitle": "TME Alteration in HER2 Positive Breast Cancer",
    "officialTitle": "Tumor Microenvironment Alteration During Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, HER2-positive Breast Cancer, Chemotherapy Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "tumor microenvironment alteration",
    "eligibilityCriteria": "Inclusion criteria i. Adult patients over 18 years of age ii. Patients undergoing curative treatment including neoadjuvant chemotherapy after confirmation of breast cancer without distant metastases iii. Clinical T stage II-IV patients iv. HER2 positive breast cancer patients\n\nExclusion criteria If you have other comorbidities that, according to the researcher's judgment, may affect the results of the study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}